Lunate Capital Ltd — 13F Holdings & Portfolio

CIK 2056786 · latest 13F-HR filed 2026-07-23

Lunate Capital Ltd manages $196.0M in 13F-reported U.S. long-equity assets across 10 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SAIL (22.41%), BIRK (22.17%), LINE (13.24%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 6 new positions, exited 2, added to 3, and trimmed 1.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
UNIT 1, FLOOR 12, AL MARYAH TOWER
ABU DHABI GLOBAL MARKET SQUARE
AL MARYAH ISLAND, ABU DHABI, C0 00000
Phone
971.2.877.8896
Filing Manager
Lunate Capital Ltd
AL MARYAH ISLAND, ABU DHABI, C0
Signatory
Khalifa Sultan Sultan Hazim Alsuwaidi
Managing Partner
Loading holdings…
AUM

$196.0M

Long-equity book

Holdings

10

Distinct positions

Period

2026-06-30

Filed 2026-07-23

Q/Q Activity

+6 / −2 / ↑3 / ↓1

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • LINEAGE INC$6.3M +32.0%
  • SAILPOINT INC$4.2M +10.6%
  • NAVAN INC$1.9M +72.7%
Show all 3

Top Trims

  • NEUMORA THERAPEUTICS INC.-$531.0K -12.8%
Show all 1

New Positions

  • BIRKENSTOCK HOLDING PLC$43.5M
  • BLACKSTONE SECD LENDING FD$23.7M
  • GOLDMAN SACHS BDC INC$20.8M
  • MORGAN STANLEY DIRECT LENDIN$16.7M
  • BLUE OWL CAPITAL CORPORATION$13.0M
Show all 6

Exited Positions

  • REVOLUTION MEDICINES INC$53.4M
  • REVOLUTION MEDICINES INC$805.5K
Show all 2
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 SAILPOINT INC SAIL 78781J109 $43.9M 22.41% 3,000,000 SH
2 BIRKENSTOCK HOLDING PLC BIRK M2029K104 $43.5M 22.17% 1,010,000 SH
3 LINEAGE INC LINE 53566V106 $25.9M 13.24% 600,000 SH
4 BLACKSTONE SECD LENDING FD BXSL 09261X102 $23.7M 12.11% 1,000,818 SH
5 GOLDMAN SACHS BDC INC GSBD 38147U107 $20.8M 10.60% 2,192,392 SH
6 MORGAN STANLEY DIRECT LENDIN MSDL 61774A103 $16.7M 8.51% 1,103,814 SH
7 BLUE OWL CAPITAL CORPORATION OBDC 69121K104 $13.0M 6.66% 1,200,244 SH
8 NAVAN INC NAVN 639193101 $4.6M 2.33% 200,000 SH
9 NEUMORA THERAPEUTICS INC. NMRA 640979100 $3.6M 1.84% 2,124,143 SH
10 FIGMA INC FIG 316841105 $240.4K 0.12% 13,290 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-07-23 $196.0M 10 0001011438-26-000429
2026-03-31 2026-04-16 $120.4M 6 0001011438-26-000235
2025-12-31 2026-01-23 $264.3M 6 0001011438-26-000036